Skip to content
Indigenous, Medical Health Aged Care

Monash expert: Improving bone health in First Nations communities

Monash University 2 mins read

As NAIDOC Week continues, a Monash University study published in the MJA  has found that increasing bone health awareness across Indigenous communities by a Community-led, co-created education program was valued as it would be beneficial for Indigenous people across the life course.

“To be effective, incorporating traditional Indigenous ways and knowledge along with presentday health evidence is required,” the researchers found.


Available to comment:


Dr Troy Walker, who did this work with the Monash School of Clinical Sciences at Monash Health, Department of Medicine
Contact: +61 3 9903 4840 or [email protected]

  • Musculoskeletal health, strength and conditioning, Aboriginal health

  • Diet, nutrition, lifestyle medicine

  • Clinical pain management, social and emotional wellbeing, neuromusculoskeletal rehabilitation

Comments attributable to Dr Walker:

“There is a higher prevalence of bonerelated conditions among Aboriginal and Torres Strait Islander people compared with nonIndigenous Australians. Despite the impact of falls on First Nations health, current policy lacks focus on bone conditions, and pain is often a pertinent finding to establish underlying fracture and disease.


“Understanding perspectives and beliefs about bone health in the Aboriginal and Torres Strait Islander population is essential for designing effective, culturally safe programs and services. We explored the perspectives, beliefs and knowledge on bone health among Aboriginal and Torres Strait Islander adults in Victoria, and topics considered essential to increase Community health literacy by co
creating an educational program for Community members.


“Our key findings show that participants were aware of the importance of exercise for bone health, specifically high intensity and loading exercises were beneficial for bone health. Holistic health, including connection to Country, preventive screening and raising awareness, and other lifestyle factors and their relationship to musculoskeletal health were highlighted.


“Increasing musculoskeletal health literacy by incorporating co
created Community education, embedded in principles of health promotion, was valued by Aboriginal and Torres Strait Islander people across the life course. To be effective, incorporating traditional Indigenous Ways of Knowing, Doing and Being with presentday health evidence is required.

“With the information gathered, we have now co-created an educational program on musculoskeletal health and have worked with and learned from our Aboriginal healthcare workers to deliver the program across the various Aboriginal health services that we have consulted with in Victoria. We envision to widen the reach and impact by rolling this out nationwide in the next few years.”

For more experts, news, opinion and analysis, visit Monash News.
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or [email protected] 

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.